CalciMedica Inc (CALC)

Currency in USD
5.130
-0.150(-2.84%)
Closed·
5.1300.000(0.00%)
·
CALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.1305.591
52 wk Range
1.4207.200
Key Statistics
Prev. Close
5.28
Open
5.23
Day's Range
5.13-5.591
52 wk Range
1.42-7.2
Volume
26.96K
Average Volume (3m)
82.44K
1-Year Change
66.0194%
Book Value / Share
-0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CALC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.250
Upside
+216.76%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

CalciMedica Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

CalciMedica Company Profile

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company’s lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

Compare CALC to Peers and Sector

Metrics to compare
CALC
Peers
Sector
Relationship
P/E Ratio
−3.2x−1.2x−0.6x
PEG Ratio
0.26−0.020.00
Price/Book
−275.8x1.3x2.6x
Price / LTM Sales
-7.5x3.4x
Upside (Analyst Target)
202.1%470.5%39.6%
Fair Value Upside
Unlock11.9%5.2%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.250
(+216.76% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy20.00+289.86%-Maintain02/12/2025
H.C. Wainwright
Buy16.00+211.89%-Maintain01/04/2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.52 / -1.73
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

5.20
PEPG
+4.21%
3.740
RLMD
-1.58%
4.700
IMMX
-0.21%
26.07
SEPN
-4.78%
7.39
LXEO
-1.47%

FAQ

What Is the CalciMedica (CALC) Share Price Today?

The live CalciMedica share price today is 5.130

What Stock Exchange Does CalciMedica (CALC) Trade On?

CalciMedica is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for CalciMedica?

The stock symbol (also called a 'ticker') for CalciMedica is "CALC."

What Is the Current CalciMedica Market Cap?

As of today, CalciMedica market capitalisation is 73.92M.

What Is CalciMedica's (CALC) Earnings Per Share (TTM)?

The CalciMedica EPS is currently -1.61 (Trailing Twelve Months).

Is CALC a Buy or Sell From a Technical Analyst Perspective?

Based on today's CalciMedica moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has CalciMedica Stock Split?

CalciMedica has split 1 times. (See the CALC stock split history page for full effective split date and price information.)

How Many Employees Does CalciMedica Have?

CalciMedica has 15 employees.

What is the current trading status of CalciMedica (CALC)?

As of 19 Jan 2026, CalciMedica (CALC) is trading at a price of 5.130, with a previous close of 5.280. The stock has fluctuated within a day range of 5.130 to 5.591, while its 52-week range spans from 1.420 to 7.200.

What Is CalciMedica (CALC) Price Target According to Analysts?

The average 12-month price target for CalciMedica is USD16.25, with a high estimate of USD20 and a low estimate of USD14. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +216.76% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.